(Q24250226)

6 August 2017

1 reference

title

Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment (English)

1 reference

6 August 2017

0 references

E. Haydn Walters

1

0 references

Julia AE Walters

2

0 references

Peter G Gibson

3

0 references

Paul Jones

4

0 references

E H Walters

1

1 reference

PubMed ID

12804401

6 August 2017

J Walters

2

1 reference

6 August 2017

20 January 2003

0 references

1 January 2003

1 reference

Cochrane Database of Systematic Reviews

6 August 2017

1 reference

6 August 2017

CD001285

1 reference

6 August 2017

2

1 reference

Long-term regularly inhaled salbutamol

6 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Beta2-agonist tolerance and exercise-induced bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Asthma control during and after cessation of regular beta 2-agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

A Three Month Study of the Bronchodilator Effects of Aerosolized Fenoterol and Isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Evaluation of tolerance after continuous and prolonged oral administration of salbutamol to asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Evaluation of Oral Fenoterol in Chronic Asthmatic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Regular Inhaled Beta-Adrenergic Agonists in the Treatment of Bronchial Asthma: Beneficial or Detrimental?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

An explanation of the asthma paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

The effect of regular inhaled albuterol on exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Hemodynamic effects of an inhaled beta-2 agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

How detrimental is chronic use of bronchodilators in asthma and chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular versus symptomatic aerosol bronchodilator treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics *1A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Clinical implications of drug-induced desensitization of the beta receptor after continuous oral use of terbutaline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Asthma drug therapy trends in the United States, 1972 to 1985

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regularly inhaled beta-agonists with steroids are not harmful in stable asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effects of treatment with formoterol on bronchoprotection against methacholine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

The beta-agonist controversy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular use of inhaled albuterol and the allergen-induced late asthmatic response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

The effect of inhaled albuterol in moderate to severe asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Isoprenaline resistance and the use of pressurised aerosols in asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular versus as-needed inhaled salbutamol in asthma control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular vs as-needed inhaled salbutamol in asthma control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (2). Why beta-agonists should not be used regularly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Tolerance to beta-agonists during acute bronchoconstriction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effects of on-demand beta2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Does the continuous use of bronchodilators mask the progression of asthma or chronic bronchitis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Inhaled salbutamol for wheezy infants: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Beta agonists in asthma--state of the art: report on a Royal Society of Medicine seminar

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effect of regular terbutaline on the airway response to inhaled budesonide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Intermittent and continuous salbutamol rotacaps inhalation in asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Influence of beta-adrenergic receptor function during terbutaline treatment on allergen sensitivity and bronchodilator response to terbutaline in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Increased Inhaled Bronchodilator vs Increased Inhaled Corticosteroid in the Control of Moderate Asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

The Effect of Regular Salbutamol on Lung Function and Bronchial Hyperresponsiveness in Normal Subjects and Nonasthmatic Atopic Subjects With Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Nonprescription bronchodilator medication use in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Assessment of Tachyphylaxis following Prolonged Therapy of Asthma with Inhaled Albuterol Aerosol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

International trends in asthma mortality: 1970 to 1985.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Changes in bronchial reactivity in asthmatic children after treatment with beclomethasone alone or in association with salbutamol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

Short-term regular beta 2-adrenergic agonists treatment is safe in mild asthmatics taking low doses of inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001285

7 January 2021

10.1002/14651858.CD001285

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12804401